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Abstract
Enveloped viruses enter host cells either through endocytosis, or by direct fusion of the viral membrane envelope
and the membrane of the host cell. However, some viruses, such as HIV-1, HSV-1, and Epstein-Barr can enter
a cell through either mechanism, with the choice of pathway often a function of the ambient physical chemical
conditions, such as temperature and pH. We develop a stochastic model that describes the entry process at the
level of binding of viral glycoprotein spikes to cell membrane receptors and coreceptors. In our model, receptors
attach the cell membrane to the viral membrane, while subsequent binding of coreceptors enables fusion. The
model quantifies the competition between fusion and endocytotic entry pathways. Relative probabilities for each
pathway are computed numerically, as well as analytically in the high viral spike density limit. We delineate
parameter regimes in which fusion or endocytosis is dominant. These parameters are related to measurable and
potentially controllable quantities such as membrane bending rigidity and receptor, coreceptor, and viral spike
densities. Experimental implications of our mechanistic hypotheses are proposed and discussed.
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1 Introduction
Entry mechanisms of enveloped viruses (viruses with a surrounding outer lipid bilayer membrane) are usually
classified as being either endocytotic or fusogenic [1, 2]. In fusion, the virus membrane and the host cell membrane
become joined by a pore. Once the two membranes are contiguous, the virus can directly enter the host cell. This
process is typically mediated by binding of cell surface receptors to glycoprotein spikes on the viral membrane
surface, which trigger embedded fusion peptides. In endocytosis, the host cell first internalizes the virus particle,
wrapping it in a vesicle before either fusion with the endosomal membrane, or degradation of the virus as the
endosome is acidified. Fusion of the endosomal membrane with the viral envelope is often triggered by the acidic
environment of the endosome.
While viruses are typically thought to enter host cells via either endocytosis or fusion, there is a growing list
of viruses that are known to enter cells though both pathways. For example, influenza, the avian leukosis virus
(ALV), and Semliki Forest virus (SFV) primarily enter cells via endocytosis followed by endosomal fusion triggered
by low pH. However, they have also been observed to directly fuse with host cells if the pH of the extracellular
environment is lowered [3–5]. For some viruses (e.g., Influenza), the glycoprotein-receptor complexes that bind the
virus to the cell membrane initiate fusion under acidic conditions encountered later in the process. Many other
viruses require the binding of multiple cell surface receptors by multiple viral glycoproteins for entry, and several
such viruses have also been observed to enter cells through their non-dominant pathway.
At least three of the twelve types of glycoproteins in the envelope of the Herpes Simplex Virus-1 (HSV-1)
bind cell surface receptors as integral steps in viral entry. As an initial step, glycoproteins gB and gC bind to
heparan sulfate (HS) proteoglycans on the cell surface, attaching the virus to the host cell. Once the viral and
host cell membranes are brought close to each other, glycoprotein gD can associate with any of a number of
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cell receptors, including Herpesvirus entry mediator (a tumor necrosis factor receptor), nectin-1 (a member of
the immunoglobulin superfamily), and 3-O-sulfated heparan sulphate (HS), to trigger fusion. HSV-1 is known to
exploit at least three entry pathways: direct fusion with the host cell membrane, endocytosis followed by fusion
with an acidic endosome, and endocytosis followed by fusion with a neutral endosome [6].
Epstein-Barr virus, another member of the Herpes virus family, requires the binding of multiple glycoproteins to
cell surface receptors during entry. When Epstein-Barr virions enter B-cells, the glycoprotein complex gp350/220
binds to complement receptor type II (CR2) to attach the virus to the host B-cell. Fusion of the virus with the cell
membrane or endosome requires that glycoprotein gp42 associate with a HLA class II protein on the cell surface
[7]. It is thought that the virus and cell membranes must be brought close by gp350/220-CR2 binding before gp42
can bind a HLA class II protein. While the Epstein-Barr virus typically enters B cells by endocytosis, eventually
fusing with the endosome, it enters epithelial cells by direct fusion with the plasma membrane. There are at least
three models for the entry of Epstein-Barr virus into epithelial cells. 1) An interaction between gp350/220 on
the virus and CR2 on the cell brings the membranes close. Viral glycoprotein complex gHgL can then interact
with gHgL receptor on the cell, triggering fusion. 2) The viral glycoprotein complex may directly interact with
its receptor on the cell membrane, triggering fusion. 3) The viral protein encoded by BMRF2 may interact with
integrins on the cell surface followed by gHgL-gHgLr binding [8].
Human immunodeficiency virus (HIV) has also been shown to exploit both entry mechanisms. HIV requires a
receptor, CD4, for endocytosis, and both CD4 and a coreceptor, usually CXCR4 or CCR5 to fuse with the host
cell membrane [9, 10]. The HIV coreceptor binds to the viral glycoprotein gp120 with a much higher affinity if
the glycoprotein spike is already bound to a CD4 receptor [11–13]. HIV infects cells with which it fuses, and is
typically inactivated upon endocytosis [10].
A previous study [14] has examined the dynamics of viral entry when a single type of cell receptor attaches the
virus to the cell membrane and induces fusion. In this paper, we develop a stochastic model that describes viral
entry pathways in which binding of a receptor to viral glycoprotein spikes is followed by binding of a coreceptor
to viral spikes. In this model, the receptors are only attachment factors and the coreceptors induce fusion. The
coreceptors and receptors may both bind to the same viral glycoprotein, as is the case for HIV, or they may bind to
different glycoproteins or sets of glycoproteins, as is the case for HSV-1 and the Epstein-Barr virus. The selection
of entry pathway is computed as a function of the kinetic rates in the model. We will discuss the sensitivity of
pathway selection to the local co-receptor-mediated fusion rate and the rate of coreceptor binding.
Table 1 lists relevant physical parameters for HIV-1 and HSV that guide assumptions of our model. Parameters
values relevant to our model, but not readily available, are left blank and await future experimental investigation.
2 Kinetic Model for Receptor-Coreceptor Engagement
Here, we derive a stochastic model describing the competition between the endocytic and fusion viral entry
pathways. We assume that receptors on a host cell membrane can bind to any one of M spikes uniformly
distributed on the surface of a single virus, and that coreceptors can bind to any one of N spikes, which may be
different from the spikes to which receptors bind (see Fig. 1). Receptor binding locally attaches the virus envelope
to the cell membrane, while coreceptor binding leads to the formation of fusion-enabling complexes. For simplicity,
we consider the binding of both receptors and coreceptors to be irreversible. Since binding interactions between
receptors and spikes can be very strong and/or have low dissociation constants (see Table 1), this approximation is
consistent with physical parameters relevant to many viruses. However, there is also evidence that the CD4-gp120
interaction is weak and can dissociate during coreceptor recruitment [15].
We assume that only those coreceptor-binding spikes in a region where spikes are bound to receptors can bind
coreceptors. This assumption is appropriate if the receptors act as the attachment factor that brings the viral
and cell membranes close enough for the coreceptor to bind. For example, the binding of CR2 receptors to the
large gp350/220 glycoprotein complex on the Epstein-Barr virus typically precedes attachment of fusion-inducing
HLA class II proteins to the smaller gp42 glycoprotein. This assumption also applies to HIV, since the affinity of
coreceptors for viral spikes increases significantly if the spike has already bound a receptor [11–13].
The ratio of coreceptor-binding spikes to receptor-binding spikes is defined by r = N/M . For viruses where
attachment receptors and fusion initiating coreceptors attach to the same glycoprotein spike, such as HIV-1, we
can simply set r = 1 in our model. Although we assume that each spike can bind at most only one receptor and/or
one coreceptor, experimentally inferred stoichiometries range from one to a handful [16–18]. Our model can be
straightforwardly adapted to describe specific receptor/coreceptor/spike stoichiometries.
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In order for endocytosis to occur, the virus must be fully wrapped by the cell membrane. We assume that
when the virus is fully wrapped all receptor-binding spikes have a receptor attached. However, as more of the
cell membrane contacts the virus membrane through receptor binding, the rate of binding of fusion-inducing
coreceptors increases and fusion is increasingly likely. It has been shown that for HIV, viral spikes act independently
to induce fusion [19], so we assume that the fusion rate is proportional to the number of viral spike-receptor-
coreceptor complexes. Although it is possible that spike-receptor-coreceptor complexes that induce fusion do
so in a cooperative manner, we are not aware of any evidence that complexes aggregate in order to initiate a
cooperative response. From a modeling perspective, and in light of experimental evidence [19], the most reasonable
assumption is that the randomly distributed spike-receptor-coreceptor complexes locally induce irreversible fusion
pore formation in an independent and Poissonian manner. Thus, the total viral fusion rate increases linearly with
the number of spike-receptor-coreceptor complexes formed. Within our stochastic model, the likely pathway of
virus entry, endocytosis or fusion, will also depend on the specific rates of receptor and coreceptor binding.
A mathematical framework representing our stochastic model is found by considering, at any given time t,
the probability Pm,n(t) that m spikes are bound to a receptor and n spikes are bound to a coreceptor. With the
following definition of the relevant rates in our problem
• pm,n: rate of binding an additional receptor
• qm,n: rate of binding an additional coreceptor
• kf : fusion rate for each spike-receptor-coreceptor complex
• ke: rate of endocytosis (membrane pinch-off) when all viral spikes are receptor-bound (m =M),
the probability Pm,n(t) evolves according to the Master equation
∂Pm,n(t)
∂t
= pm−1,nPm−1,n + qm,n−1Pm,n−1 1 ≤ m ≤ N − 1, 1 ≤ n ≤ n∗ − 1
−(pm,n + qm,n + nkf )Pm,n, n∗(m) ≡ int(rm)
∂Pm,n∗(t)
∂t
= qm,n∗−1Pm,n∗−1 − (pm,n∗−1 + n∗kf )Pm,n∗ , 1 ≤ m ≤M − 1
∂Pm,0(t)
∂t
= pm−1,0Pm−1,0 − (pm,0 + qm,0)Pm,0, 1 ≤ m ≤M − 1,
∂PM,n(t)
∂t
= pM−1,nPM−1,n + qM,n−1PM,n−1 1 ≤ n ≤ N − 1,
−(qM,n + nkf + ke)PM,n
(1)
∂tP0,0 = −p0,0P0,0, ∂tPM,0 = pM−1,0PM−1,0−(qM,0+ke)PM,0, and ∂tPM,N = pM−1,NPM−1,N +qM,N−1PM,N−1−
(Nkf + ke)PM,N . The process depicted in Fig. 1 and described by the above equations can be represented by
transitions within the m,n-state space shown in Fig. 2.
We treat all transitions in our model as Markovian, implicitly assuming that they do not depend on past
configurations. This assumption is appropriate if the attachment rates are kinetically limited by membrane
fluctuations or by receptor/coreceptor binding, rather than by diffusion. Diffusion-limited binding of receptors
and coreceptors gives rise to history-dependent kinetics and must be treated within the framework of stochastic
moving boundary problems. Deterministic moving boundary problems relevant for virus wrapping are treated in
[20] and [21]. For binding kinetics to not be diffusion-limited, receptors and coreceptors must diffuse fast enough
to replenish a receptor-depleted region before the next binding event occurs. The time required for concentration
variations to diffuse away is ar,c/Dr,c, where ar and ac are the typical areas per receptor and coreceptor on the
cell surface, and Dr and Dc are their diffusion coefficients in the cell membrane. Therefore, provided
pm,n ≪ Dr/ar and qm,n ≪ Dc/ac, (2)
the history-independent binding assumption is justified. For the HIV infection systems, CD4 receptor and CCR5
coreceptor concentrations are approximately 103/µm2 and 60/µm2, respectively. Upon using the cell surface
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receptor and coreceptor diffusion coefficients in Table 1, we find that pm,n ≪ 50/s and qm,n ≪ 3/s are required
for CD4 and CCR5 engagement to be kinetically limited, and not diffusion-limited.
Although our main qualitative findings are independent of the precise form for the attachment rates pm,n and
qm,n, we nonetheless examine a specific physical model for these rates. First, assume that a receptor binds, with
rate pm,n, to only those spikes that are within some small distance ℓ of the contact line L(m) (see Fig. 3) where
the membrane detaches from the virus. A functional form for this rate can be derived by considering the number
of ways additional receptors can bind, given that there are already m receptor-spike complexes making up the
contact region. Fluctuations of the cell membrane will be distributed in size with a typical scale ℓ (Fig. 3).
The plasma membrane fluctuations, either thermally excited, or driven by cellular processes such as cytoskeletal
reorganization [22], can be caught by the virus if they bring a receptor into the proximity of a spike. As shown
in Fig. 3, the membrane wrapping process is a Brownian ratchet that uses the spikes within a distance ℓ of
the contact line of length L(m) to catch the cell membrane fluctuations. The rate of attachment of an additional
receptor can be written as pm,n ∼ ωℓL(m)a−1s a−1r , where ω is an intrinsic attempt rate for binding and fluctuations
of typical size ℓ, a−1s is the viral spike concentration, and a
−1
r is the receptor concentration on the cell membrane.
The term ℓL(m)a−1s represents the probability that a membrane fluctuation of typical size ℓ will encounter a
spike on the viral surface when m receptors have already previously bound. The approximate spherical geometry
of this system gives L(m) ≈ [1− (1− 2m/M)2]1/2, and since the area per spike is as ≈ 4πR2/M , we find the
coreceptor-independent, receptor binding rate
pm(M) ≈ ωℓM
4πR2ar
√
1−
(
1− 2m
M
)2
≡ p1M
√
1−
(
1− 2m
M
)2
, 1 ≤ m ≤M − 1,
(3)
where p1M is the intrinsic rate of binding the second receptor when initially one is bound. This intrinsic rate
depends on a number of physical parameters such as cell membrane bending rigidity (through ℓ and ω) and cell
surface receptor concentration. For stiff membranes under tension, a membrane wrapping a spherical particle
encounters an energy barrier near half-wrapping [23]. This can be incorporated into the dynamics by assuming
p1 has an M dependence with a minimum near m ≈ M/2. Other forms for pm,n can also be motivated [24] by
considering the mechanics of wrapping [25].
The binding rate of coreceptors will be proportional to the integer number of receptor-spike complexes that
have not yet bound to coreceptors:
qm,n ≈ q1,0int(rm− n) ≡ q1(n∗(m)− n), (4)
where q1 is the intrinsic rate of a coreceptor binding to to a spike-receptor complex.
Finally, we describe the fusion and endocytosis steps. The rates of these processes, kf and ke, are the least
well measured. The individual fusion rates kf depend not only on the particular spike-receptor complex, but may
also depend on other molecular factors such as the lipid composition. In model systems involving the gp41 fusion
peptide of the HIV-1 glycoprotein-receptor complex, the fusion rate was found to be of the order kf ∼ 0.01/s
[26]. Physical models for kf can also be motivated from phenomenological considerations of fusion intermediates
[27–30] and/or estimated from computer simulations [30, 31].
The pinching-off of membrane vesicles in endocytosis is potentially a more complex process activated by
GTPases such as dynamin [32]. The kinetics of this process may be akin to the “kiss and run” fast mode of
endocytosis at neuronal synapses. A wide range of rates (0.1/s < ke < 20/s) for synaptic vesicle kinetics has been
reported [33].
3 Numerical Solution of Master Equation
Solutions to Eq. 1 can be found numerically for up to reasonably large values of M and N . From the resulting
probabilities, we construct time-independent quantities of interest.
The total time integrated probability Qe that the virus undergoes endocytosis can be constructed from
Qe = ke
N∑
n=1
∫ ∞
0
PM,n(t)dt. (5)
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Similarly, the total time integrated probability Qf that the virus undergoes fusion is
Qf = kf
∑
m,n≤n∗
n
∫ ∞
0
Pm,n(t)dt = 1−Qe, (6)
where the last equality arises from conservation of probability and the assumption of non detaching receptors.
We solve for Qe and Qf by taking the Laplace transform of Eq. 1 and setting s = 0. If we define P˜m,n =∫∞
0−
e−stPm,n(t)dt, then the endocytosis and fusion probabilities can be expressed as Qe =
∑
n keP˜m,n(s = 0) and
Qf =
∑
m,n≤n∗ nkf P˜m,n(s = 0), respectively. We can also find the mean times 〈Te〉 to viral entry, conditioned
upon endocytosis, or 〈Tf〉, conditioned upon fusion:
〈Te〉 = keQ−1e
N∑
n=1
∫ ∞
0
tPM,n(t)dt
= −keQ−1e
N∑
n=1
∂P˜M,n(s = 0)
∂s
(7)
and
〈Tf〉 = kfQ−1f
∑
m,n<rm
n
∫ ∞
0
tPm,n(t)dt
= −kfQ−1f
∑
m,n≤n∗
n
∂P˜m,n(s = 0)
∂s
.
(8)
Finally, crucial to experimental considerations of spike-receptor-coreceptor stoichiometry [34], we also compute
the mean numbers of receptors and coreceptors bound to the virus at the moment of entry. The mean number of
receptors bound at the moment of fusion is found from
〈mf 〉 = Q−1f
∑
m,n≤n∗
mnkf P˜m,n(s = 0). (9)
The mean numbers of coreceptors bound at the moment of fusion, and the mean number of coreceptors bound at
the moment of endocytosis (when all N receptors are bound) can be similarly obtained.
4 Results and Analysis
In this section, we discuss solutions of the Master Equation (Eq. 1) outlined in Section 2. For simplicity, consider
that the ratio of the number of spikes that can bind coreceptors to the number of spikes that can bind receptors
is r = 1 and that M = N . This implies either that the number of receptor-binding spikes equals the number of
coreceptor binding spikes, or that receptors and coreceptors both bind the same spikes, as is the case for HIV.
The results for r 6= 1 are qualitatively similar to the results of r = 1 when the replacement kf → rkf is made (see
Appendix).
4.1 Pathway probabilities
We first explore how the probability that the virus undergoes endocytosis, Qe, depends on problem parameters.
Since Qe +Qf = 1, it is sufficient to consider only Qe. In Fig. 4(a), Qe is plotted as a function of the normalized
fusion rate, kf/p1, for different values of the normalized intrinsic coreceptor binding rate, q1/p1. The number of
viral spikes, M = N , was chosen to be 100. The probability that the virus undergoes endocytosis decreases with
increasing fusion rate, but a small coreceptor binding rate can attenuate fusion even when kf is large. In Figure
4(b), we plot the probability that the virus undergoes endocytosis as a function of normalized fusion rate, kf/p1,
for different values of the normalized endocytosis rate, ke/p1.
The dependence of the endocytosis probability, Qe, on the number of viral spikes, M , is shown in Fig. 5.
Although the binding rate, pm increases with M (see Eq. 3), so do the number of spikes that need to be engaged
by receptors to achieve the full wrapping required for endocytosis. The time required to fully wrap the virus
is therefore constant with respect to M . However, the fusion rate is proportional to the number of spikes with
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coreceptors bound and is thus proportional to N . As N increases, the probability that the particle undergoes
fusion before it becomes fully wrapped increases, as illustrated by Fig. 5. Figures 4 and 5 clearly show a marked
decrease in the endocytosis probability as the fusion rate kf is increased.
Since kf may vary greatly depending on physical chemical conditions, as well as on viral species, it is important
to estimate the values of kf for which endocytosis or fusion is the dominant mode of entry. To better understand
how Qe depends on kf , we consider the continuum limit of Eq. 1, appropriate for large M,N . The probabilities
of full wrapping and endocytosis, as well as times to fusion and endocytosis, can be calculated analytically by the
method of characteristics (see Appendix). Figure 6 compares our continuum limit analytic solution with the exact
numeric solution and agreement is good for M,N & 100. The analytic solution (see Eq. 30 in Appendix) provides
a guide for estimating the parameters for which endocytosis is likely.
Let us now dissect the entry dynamics and estimate values of ke and kf for which endocytosis will occur. For
certain parameters, the virus is likely to fuse before it becomes fully wrapped. In this case, the probability that
the virus reaches the fully wrapped state will be small, and fusion will be the dominant mode of entry. Only if
the virus is likely to become fully wrapped is endocytosis a possible alternative to fusion. Endocytosis will occur
only if the probability that M receptors become bound to the virus, PM , is order 1 and endocytosis occurs more
quickly than fusion once the virus is fully wrapped. For single receptor-spike complexes that attach membranes
and induce fusion [14], previous asymptotic analysis showed that(
kfM
2
pm
)
≪ 1 (10)
must be satisfied in order for the virus to become fully wrapped. In that analysis, pm was a typical receptor
binding rate.
Analogous conditions for endocytosis can be found when both receptor and coreceptor binding are required
for fusion. These conditions can be found numerically by computing Qe from Eqs. 1 and 5. However, upon using
the specific forms for the receptor and coreceptor binding rates given by Eqs. 3 and 4, the conditions can also be
deduced from the wrapping probability PM in the large M limit. From Eq. 25 in the Appendix,
lnPM ≈ −rkfM
2p1
[
π
2
− 1
2λ
+
e−λpi − λ2
2λ(λ2 + 1)
]
, (11)
where λ = q1/(2p1). This asymptotic expression allows us to determine when the wrapping probability is appre-
ciable. If coreceptors are required for fusion, as considered in this study, the expected behavior will be similar to
the single receptor model only if coreceptor binding is faster than receptor binding. Indeed, when q1 & p1 (λ & 1),
we find that the condition
rkfM
p1
≪ 1 (12)
is required for full wrapping. Since pm ∼ p1M , we recover the condition (Eq. 10 here) given in [14] when r = 1.
Figure 7(a) shows the numerically computed probability of full wrapping, PM , as a function of rkfM/p1 (with
r = 1). The condition for full wrapping given by Eq. 12 holds even when parameters are individually varied over
a wide range of values.
Now consider the condition for full wrapping when coreceptor binding is slow compared to receptor binding.
For extremely small q1/p1 = 2λ ≪ 1/N , the M,N → ∞ continuum limit for PM (Eq. 11) is not appropriate.
When coreceptor binding is extremely small, no coreceptors bind, and the virus always becomes fully wrapped
independent of kf . However, for 1/N ≪ q1/p1 ≪ 1, (or 1/N ≪ λ ≪ 1). The condition for PM ∼ 1 derived from
Eq. 11 is (
rkfM
p1
)(
q1
p1
)
≪ 1. (13)
If condition 12 is satisfied, condition 13 will be satisfied provided that q1 ≤ p1. Thus, condition 12 is sufficient for
the virus to become fully wrapped; however, because slow coreceptor binding can limit the effects of a fast fusion
rate, condition 12 is not necessary, particularly when coreceptor binding is slow. In other words, even if rkfM/p1
is large, as long as q1/p1 is small enough, condition 13 can still be satisfied and full wrapping can still occur. In
Fig. 7(b), PM is plotted as a function of (rkfM/p1)(q1/p1) with various parameters independently varied. When
coreceptor binding is slow, the condition given by Eq. 13 is found to predict whether the virus is likely to reach
the fully wrapped state. Although we have used the particular binding rates pm and qm,n from Eqs. 3 and 4,
analogous conditions for PM ∼ 1 can be motivated for general binding rates (see Appendix).
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We can now derive sufficient conditions for endocytosis after the virus becomes fully wrapped. In the case
where the coreceptor binding rate is large compared to the receptor binding rate, we expect that when the virus
reaches the fully wrapped state, nearly all N spikes will be coreceptor-bound. Once the virus is fully wrapped, it
fuses with the cell membrane with total (and maximal) rate Nkf , while it is endocytosed by the cell with rate ke.
Thus, endocytosis will be the dominant mode of viral entry if
ke ≫ kfN = rkfM. (14)
Provided the virus has a high probability of reaching the fully wrapped state, ke ≫ Nkf is always a sufficient,
but not always a necessary condition for endocytosis. When coreceptor binding is not fast, we will typically need
to consider the full solution given by Eq. 30 in order to determine when endocytosis is likely. However, we can
consider the limiting case where the coreceptor binding rate is small compared to both the receptor binding rate
(q1 ≪ p1), and the fusion rate (q1N ≪ kf ). In this case, we can assume that fusion is limited by the coreceptor
binding rate, and the condition required for efficient endocytosis is
ke ≫ q1N = rq1M. (15)
The conditions described above for efficient endocytosis are summarized in the Discussion and Conclusions section
and delineated in a parameter-space “phase diagram.”
4.2 Mean entry times
We now investigate 〈Te〉, the mean viral entry time via the endocytosis pathway, and 〈Tf 〉, the mean entry time
via the fusion pathway. The normalized mean times are computed from Eqs. 7 and 8 and are plotted in Fig.
8 as a function of the fusion rate per bound coreceptor, kf . Endocytosis is governed by two potentially rate-
limiting steps: viral wrapping, and the final endocytosis step (pinching-off of the cell membrane). For small ke,
the endocytosis step is rate limiting, and 〈Te〉 scales as 1/ke when Qe ≈ 1. For the parameters used in Fig. 8(a),
the receptor binding rates are much faster than the endocytosis rate; thus, ke is the limiting rate constant. As the
fusion rate kf increases, both the probability of endocytosis, Qe, and the mean endocytosis times, 〈Te〉, decrease.
One might initially expect 〈Tf〉, but not 〈Te〉 to decrease with increasing kf . However, we expect there to be some
distribution of times at which the virus becomes fully wrapped. A larger fusion rate will preferentially annihilate
trajectories that take longer to reach the fully wrapped state. Therefore, only trajectories that quickly reach the
fully wrapped state survive to m = M and participate in endocytosis, resulting in a decreased 〈Te〉 when kf is
increased.
In Fig. 8(b), we plot the normalized mean entry times as a function of ke/p1, the normalized endocytosis rate.
We find that as we increase ke, the mean time 〈Te〉 decreases and then plateaus. The plateau occurs when ke is
sufficiently fast that endocytosis is no longer rate-limiting. Rather, membrane wrapping is the rate limiting step,
and 〈Te〉 becomes independent of ke.
4.3 Mean receptor/coreceptors bound at entry
Finally, consider the mean numbers of receptors and coreceptors bound to the virus at the time of entry. In
Fig. 9(a), we plot 〈mf 〉, the mean number of receptors bound when fusion occurs, and 〈m〉, the mean number of
receptors bound when the virus enters the cell through either pathway, as functions of q1, the coreceptor binding
rate. As q1 increases, Qe decreases, and the virus is more likely to fuse with the host cell. Because the virus fuses
more rapidly, there is less time for receptors to bind and 〈m〉 decreases. Fig. 9(b) shows the mean number of
coreceptors bound to the virus at the time of entry. For very small coreceptor binding rates, the virus typically
undergoes endocytosis before a coreceptor can bind, and 〈ne〉 ≪ 1, where 〈ne〉 is the mean number of coreceptors
bound when the virus undergoes endocytosis. However, at least one coreceptor must bind for fusion to occur;
therefore, when q1 is small, the conditional mean number of bound coreceptors 〈nf 〉 ≈ 1. As q1 becomes large,
the probability that the virus undergoes endocytosis becomes small, but the mean number of coreceptors bound
to the viruses that do undergo endocytosis approaches N = 100. We know that when q1 is large, n ≈ rm. Since
full wrapping (m =M) is required for endocytosis to occur, we also expect 〈ne〉 ≈ N .
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5 Discussion and Conclusions
We have developed a stochastic model describing the binding of receptors and coreceptors to viral glycoprotein
spikes, and the subsequent competition between endocytosis and fusion during entry of enveloped viruses. Recep-
tors function as simple attachment factors in our model, while subsequent binding of coreceptors enables fusion.
We found parameter regimes in which endocytosis is favored and derived analytic expressions for the probability
of endocytosis in the large spike number limit (M,N → ∞). Since the endocytosis and fusion rates, ke and kf ,
are difficult to measure, we summarize our results by a (kf − ke) “phase diagram” defined by conditions 12, 13,
14, and 15 and shown schematically in Fig. 10.
Our model provides a mechanistic basis for a number of experimental measurements and observations. For
example, the dual entry pathways of certain viruses suggest that under certain conditions (delineated in Fig. 10)
inhibition of fusion does not necessarily preclude viral entry through endocytosis. HIV fusion inhibitors such as
Enfuvirtide (T-20) bind the intermediary spike-CD4 complex of HIV-1 [35, 36], and reduce kf by preventing CCR5
from inducing fusion. Maraviroc binds CCR5 and prevents it from binding the spike-CD4 complex, effectively
reducing q1 and also preventing fusion [37]. Since the virus may still enter through the endocytosis pathway, our
analysis suggests that the effectiveness of fusion inhibitors relies on endocytic entry being less infective than fusion.
The sensitivity of entry of HIV strains to cell CD4 and CCR5 levels have recently been quantitatively studied
using cells lines in which expression levels of receptor and coreceptor can be independently varied [38]. This system
provides a way of independently varying p1 and q1, and has revealed qualitatively different usage patterns by
different HIV strains. Our model provides an additional dimension to the analysis of receptor/coreceptor tropism.
If endocytic entry does not significantly diminish the probability of nuclear entry and productive infection, it is
possible that strains with similar infectivities actually prefer different entry pathways.
Infection measurements using for example, luciferase reporting of p24 coat protein levels after productive
infection, cannot directly determine entry pathways. However, using single molecule imaging techniques, both
the timing and entry pathways can be directly observed [39–41]. Such direct imaging techniques may be able to
distinguish the mean conditional times to fusion and endocytosis, particularly in systems with large fusion and
endocytosis rates as shown in Fig. 8.
Additionally, kinetic studies have been performed to extract the stoichiometry of receptors and coreceptors per
spike, per fusion event [16–18, 34, 42]. Even though our analysis was based on an intrinsic molecular stoichiometry
of one spike, one receptor, and/or one coreceptor, it implies that the apparent stoichiometry can vary depending on
the degree of wrapping, and on average, the number of spikes that are receptor/coreceptor-engaged prior to fusion
or endocytosis. The apparent stoichiometries are defined by 〈mf 〉 and 〈nf 〉 derived from our model and shown
in Fig. 9. Cells with higher surface densities of coreceptors, and hence larger q1, would more likely fuse before
significant wrapping and formation of spike-receptor-coreceptor complexes occur. Therefore, a high coreceptor
binding rate can present a lower apparent coreceptor stoichiometry. It would thus be interesting to measure
kinetics and correlate spike/receptor/coreceptor stoichiometry across viral strains with different apparent usage
stoichiometries, and across cell types with varying concentrations of surface receptors and coreceptors.
The assumption that the viral spikes are evenly distributed on the surface of the virus is valid only if the spikes
are immobile on the virus surface during the entry process. Freely diffusing glycoprotein spikes will preferentially
bind to membrane receptors or coreceptors when the spikes come near the cell membrane. Thus, spikes with
receptors and coreceptors bound would tend to cluster near the bottom of the virus, precluding full wrapping. In
this case, the probability that the virus enters the cell via fusion would be increased. It is also possible that the
viral glycoproteins form functional clusters on the viral envelope [43]. It is known that the glycoprotein spikes
of recently budded HIV-1 are associated with the underlying matrix proteins, but that proteolysis occurs during
the maturation process [44, 45]. If softening of a maturing virus particle [45] also increases glycoprotein spike
mobility, one would expect that mature HIV-1 would be biased towards using the fusion pathway.
The model we have developed considers only the rudimentary receptor engagement processes prior to fusion or
endocytosis. Nonetheless, many more complex mechanisms can be described by our model provided the effective
rate parameters are properly interpreted, or the model is augmented to include other intermediary processes.
For example, consider the possibility that binding of the virus to a cell surface receptor activates an endocytic
pathway that increases the rate by which the virus is wrapped by the cell membrane. The increased wrapping rate
may be the result of, for example, a decreased effective stiffness of the cytoskeleton that allows the virus to more
easily enter the cell [46]. An endocytotic pathway may also rely on the clustering cell surface receptors and/or
coreceptors, as observed in [47] resulting in a high local receptor/coreceptor concentration near the virus, thereby
effectively increasing the rate of receptor, and possibly coreceptor binding.
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Such a viral entry process can be incorporated within our model by assuming that prior to activation, receptors
and coreceptors bind with rates pi1 and q
i
1, and that after activation receptors and coreceptors bind with rates p
a
1
and qa1 , respectively. We further assume that activation occurs some time τa after the first receptor binds. And,
for simplicity, we will again consider that M = N and r = 1. In the absence of an active endocytosis process,
two conditions were required for endocytosis to occur: 1) the virus had to reach the fully wrapped state, and 2)
endocytosis had to be faster than fusion in the fully wrapped state. If, however, the cell must initiate an active
process for endocytosis, an additional condition arises: 3) the cell must reach the activated state without the
virus undergoing fusion. All three conditions must be satisfied if activated endocytosis is to occur. If activation
is important, the inactivated receptor binding rate pi1 is slow such that on average, few receptors bind before
activation occurs and pi1
√
M . 1/τa. In this case, the third condition can be described in terms of the effective
binding rates as follows.
If the inactivated coreceptor binding rate is fast compared with the time scale on which activation occurs
(qi1 & 1/τa), the virus will survive to the activated state provided τakf ≪ 1. If the inactivated coreceptor binding
rate is slow (qi1 ≪ 1/τa), it is unlikely that a coreceptor will bind before the activated state is reached, and the
virus will become activated for any kf . The delay time τa required to activate the cell’s endocytosis machinery
will be relevant if the third condition that the cell reaches the activated state before viral fusion is not met, but
conditions 1) and 2) are. In this case, a model without the activation step would predict that the virus should
undergo endocytosis when it in fact will undergo fusion. In Table 2, we summarize the criteria under which all
three activated endocytosis conditions are met.
We can also consider the case in which cells undergo clathrin or caveolin-dependent endocytosis that competes
with the fusion process [40, 48, 49]. In these cases, the membrane adhesion, or wrapping rate pm,n is no longer
a function receptor concentration, but is rather a function of the rate of assembly of clathrin subunits [50] or
calveolin, M of which cover the virus. This rate would be a function of clathrin or calveolin concentration, or of
molecules that recruit them. If the formation of clathrin pits or calveolae occurs successively in an approximately
axisymmetric manner, we expect the functional form for pm,n would be unchanged from Eq. 3. Three variants of
our model could apply to fusion under clathrin or calveolin-mediated endocytosis. 1) If coreceptors can continue
to bind viral spikes and induce fusion in regions of the membrane that are coated with clathrin or caveolin, the
model described in this work is directly applicable. In this case, monomeric clathrin/caveolin are “receptors”
and M is the total number of monomers required to encapsulate the virus. 2) If receptor binding, but not
fusion, is precluded in regions of the membrane coated by clathrin/caveolin, the coreceptor binding rate is no
longer given by qm,n = q1(n
∗(m) − n). In this case, coreceptors, like monomers of clathrin or caveolin, only
bind along the perimeter of the coated membrane region. The coreceptor binding rate then has a form similar
to the “receptor” (monomeric clathrin/caveolin) binding rate and is given by qm,n ≈ q1N
√
1− (1− 2mM )2. All
other aspects of the model would remain unchanged. 3) If coreceptors within a region of the membrane coated
by clathrin/caveolin cannot induce fusion, the virus can still undergo fusion if coreceptors bind to spikes along
the perimeter of the coated region and induce fusion before the coated region grows enough to cover the location
of the coreceptor. When coreceptor binding is fast compared to the rate at which the protein scaffold assembles,
the instantaneous fusion rate is proportional to the number of spikes near the contact region. Instead of nkf , the
effective m−dependent fusion rate kfN
√
1− (1− 2mM )2 arises. The fusion rate depends only on the number m of
bound receptors and the total number N of coreceptors. It is independent of the number n of bound coreceptors,
rendering the state space effectively one-dimensional.
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6 Appendix: Method of Characteristics
Using specific forms for the receptor and coreceptor attachment rates pm,n and qm,n, analytic expressions for the
wrapping and endocytosis probabilities can be obtained in the large spike number limit M ≡ 1/ε→∞. Assuming
binding rates given by Eqs. 3 and 4 and defining x = mε, y = rnε, and time τ = 2p1t, we find find the continuum
Mechanisms of viral entry 10
limit of the Master equation:
∂P (x, y, τ)
∂τ
+∇ · [u(x, y)P (x, y, τ)] = −κfyP (x, y, t). (16)
In Eq. 16, the convection is defined by
u(x, y) = (
√
x(1− x), λ(x − y)), (17)
where λ ≡ q1/(2p1) and κf = rkf/(2p1ε) are renormalized coreceptor binding and fusion rates. Assuming that
the system starts in the state P (x, y, 0) = δ(x − ε)δ(y) (only one receptor attached), the total derivative of
P (x(τ), y(τ), τ) obeys
dP (r(τ), τ)
dτ
= −κfy(τ)P (r(τ), τ) (18)
provided
dr(τ)
dτ
= u(x(τ), y(τ)). (19)
First consider times before the virus is fully wrapped by the cell membrane. The components of Eq. 19 give
dx(τ)
dτ
=
√
x(τ)(1 − x(τ)) (20)
and
dy(τ)
dτ
= λ(x(τ) − y(τ)). (21)
Upon using the initial conditions x(0) = ε(≈ 0) and y(0) = 0, Eqs. 20 and 21 are solved by
x(τ) =
1
2
(1− cos τ) (22)
and
y(τ) =
1
2
− λ
2 cos τ + λ sin τ + e−λτ
2(λ2 + 1)
≤ x(τ). (23)
Full wrapping of the virus, if it occurs, is defined by x(τ∗) = 1, where τ∗ = π. Therefore, at time τ = τ∗ = π, we
can find the fraction of bound coreceptors as
y(τ∗) ≡ y∗ = 2λ
2 + 1− e−λpi
2(λ2 + 1)
< 1. (24)
Using the forms for the trajectory r(τ), the probability density for times τ ≤ τ∗ can be found upon solving
Eq. 18 to give
lnP (τ) = κf
[
1
2λ
− τ
2
+
λ2(λ sin τ − cos τ) − e−λτ
2λ(λ2 + 1)
]
. (25)
The probability density P ∗ that the virus reaches the fully wrapped state (the continuum analogue of PM shown
in Fig. 7) is found by evaluating P (x(τ∗) = 1, y(τ∗) = y∗, τ∗) ≡ P ∗. This evaluation gives Eq. 11 in the large
M,N limit.
At times τ > τ∗, additional receptors cannot bind, thus, x(τ > τ∗) = 1, and y(τ) follows
dy(τ)
dτ
= λ(1 − y(τ)). (26)
Upon defining z∗ ≡ 1− y∗, Eq. 26 is solved by
y(τ > τ∗) = 1− z∗e−λ(τ−pi). (27)
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In terms of the renormalized endocytosis rate κe = ke/(2p1), the probability that the virus has not entered the
cell through either fusion or endocytosis at time τ follows
dP (x(τ), y(τ), τ)
dτ
= −(κf + κe)P (x(τ), y(τ), τ), τ > τ∗ (28)
which is solved by
P (τ) = P ∗ exp
[
− (κf + κe)(τ − τ∗)
+
κf
λ
z∗(1− e−λ(τ−τ∗))
]
.
(29)
The probability Qe that the virus particle undergoes endocytosis is then given by
Qe = κe
∫ ∞
pi
P (τ)dτ =
κe
λ
P ∗eκfz
∗/λ
(κf
λ
z∗
)−(κf+κe)/λ
γ
(
κf + κe
λ
,
κfz
∗
λ
)
. (30)
where γ is the incomplete lower Gamma function. This expression was used to generate the analytic results plotted
in Fig. 6.
Besides our results obtained using the specific forms of receptor and coreceptor binding rates, conditions
analogous to those in Eqs. 12 and 13 can also be obtain for general coreceptor-independent binding rate pm by
using simple scaling arguments. When coreceptor binding is fast, q1 & p1, the probability of fusion is approximately
kf 〈nf 〉t∗, where
t∗ ≈
M∑
m=1
1
pm
(31)
is the mean conditional wrapping time, and 〈nf 〉 is the mean number of bound coreceptors before fusion. For fast
coreceptor binding 〈nf 〉 ∼ N , and the necessary (but not sufficient) condition for full virus wrapping (PM ∼ 1) is
kfN
M∑
m=1
1
pm
= rkfM
M∑
m=1
1
pm
≪ 1. (32)
When coreceptor binding is slow, 〈nf 〉 ≈ q1Nt∗ increases linearly with both time and the number of available
coreceptor-biding spikes. In this case, the necessary condition for virus wrapping becomes
kfq1N(t
∗)2 = rkfMq1
(
M∑
m=1
1
pm
)2
≪ 1. (33)
Upon inserting the smoothly varying forms for pm from Eq. 3 into the above relationships, they reduce to the
conditions 12 and 13, respectively.
This work was supported by the National Science Foundation through grant DMS-0349195, and by the National
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Tables
Quantity HIV-1 HSV-1
radius R 0.05µm [51] 0.1µm [52]
spikes/virus
235-480 gD [53]
8-14 [54, 55] ∼700 total [43]
receptor KD ≈ 5nM [56]
binding ∆H ≈ −100kBT [56]
coreceptor KD ≈ 4nM [57]
binding ∆H ≈ −300kBT [58]
receptor diff.
const. Dr
0.044µm2/s [59]
coreceptor diff.
const. Dc
0.05µm2/s [59]
host cell radius
T-cell Epithelial cell
4µm[60] 5µm[61]
cell receptor 300-3000 6− 9× 106
density CD4/µm2 [62] HS/µm2[63]
cell coreceptor
density
60 CCR5/µm2 [62]
Table 1: Known representative parameter values for virus spikes, receptors, and coreceptors
Condition 1: Condition 2: Condition 3:
fast or survival to fast or endocytosis fast or survival to
slow fully wrapped slow faster than slow activated
def. state def. fusion def. state
fast coreceptor qa
1
pa
1
& 1
kfM
pa
1
≪ 1 qa1pa
1
& 1 ke ≫ Nkf qi1τa & 1 τakf ≪ 1binding
slow coreceptor 1
N ≪
qa
1
pa
1
≪1
(
kfM
pa
1
)(
qa
1
pa
1
)
≪1
qa
1
pa
1
≪ 1,
ke ≫ Nqa1 qi1τa ≪ 1 τ2akf qi1 ≪ 1
binding qa1N ≪ kf
Table 2: Conditions for 1) survival to fully wrapped state after activation, 2) endocytosis being faster than fusion,
and 3) reaching the activated state before fusion.
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Figure Captions
Figure 1: A schematic of the kinetic steps involved in receptor and coreceptor engagement, which ultimately lead
to membrane fusion or endocytosis. Receptors and coreceptors in the cell membrane are represented by black line
segments and red zig-zags, respectively. The projected contact area nucleated by the number of bound receptors
is also shown. Only viral spikes that have a coreceptor bound can induce fusion. Endocytosis can occur only
when the contact region grows to the surface area of the virus particle. Left: The receptors and coreceptors both
bind to the same viral spikes (blue circles). An example of such as virus is HIV-1, where spikes, likely composed
of trimers of gp120/41, bind to both CD4 and CCR5. Right: An example (such as Herpes Simplex Virus) in
which coreceptors and receptors bind to different spikes, with the ratio of receptor-binding spikes (blue circles) to
coreceptor-binding spikes (yellow hexagons) defined by r.
Figure 2: Two-dimensional state space for receptor and coreceptor-mediated viral entry. Each state corresponds
to a virus particle bound to m ≤ M receptors and n ≤ N = rM coreceptors. In this example, the fraction of
coreceptor-binding spikes to receptor-binding spikes is r = 1/2. The probability fluxes through the fusion and
endocytosis pathways are indicated by the red and green arrows, respectively. A representative trajectory of the
stochastic process that results in endocytosis is indicated by the blue dashed curve.
Figure 3: A schematic of a partially wrapped virus particle. The unbound spikes above the contact region are
represented by light blue circles, while the receptor-bound spikes in the contact region are represented by the dark
blue circles. Spikes that are bound to coreceptors are indicated by the red-filled circles. The unbound receptors
and coreceptors on the cell membrane (green) are not shown.
Figure 4: (a) The probability that the virus undergoes endocytosis is plotted as a function of the normalized fusion
rate, kf/p1, for different values of the normalized coreceptor binding rate, q1/p1. The probability of endocytosis
decreases with increasing fusion rate and, for a given fusion rate, the probability of endocytosis increases with
decreasing q1/p1. In this example, the normalized endocytosis rate, ke/p1 = 1. (b) For q1/p1 = 1, the probability
of endocytosis is plotted as a function of fusion rate for different values of the normalized endocytosis rate, ke/p1.
In both plots, the number of receptor-binding spikes and the number of coreceptor-binding spikes are set to
M = N = 100.
Figure 5: Endocytosis rates are plotted as a function of M = N . During wrapping, the fusion rate is proportional
to the number of bound coreceptors, and increases with increasing N (in this case equal to M). The probability
that the virus enters the cell through endocytosis decreases with increasing M = N .
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Figure 6: The exact numeric solution of Eqs. 1 and 5 for the probability Qe that the virus undergoes endocytosis
is plotted as a function of κf ≡ rkfM/(2p1), the dimensionless fusion rate and compared to the M → ∞
asymptotic solution (thin solid curves). Two sets of curves, corresponding to λ ≡ q1/(2p1) = 0.1, 2 are shown for
M = N = 10, 100, and 1000 (r = 1). In these plots, the endocytosis rate was taken to be ke/p1 = 2.
Figure 7: Wrapping probabilities for M = N (r = 1). (a) For q1 & p1, the probability PM that the virus reaches
the fully wrapped state is plotted as a function of the dimensionless fusion rate parameter rkfM/p1. When this
parameter is small, PM approaches unity, but when rkfM/p1 ≫ 1, PM is small. (b) When 1/N ≪ q1/p1 ≪ 1,
the wrapping probability PM is plotted as a function of the dimensionless expression (rkfM/p1)(q1/p1). In this
case the transition of PM from large to small values occurs at (rkfM/p1)(q1/p1) ∼ O(1) In both plots, only one
parameter was varied within a group of symbols of the same color and shape. The number of spikes M was varied
within the groups of circles, and the fusion rate, kf was varied within the groups of triangles.
Figure 8: (a) Normalized mean times to fusion and endocytosis plotted as functions of kf/p1, the fusion rate per
coreceptor-spike complex. Parameters used were M = N = 100, q1/p1 = 50, ke/p1 = 0.001. (b) Normalized mean
times to fusion and endocytosis plotted as functions of ke/p1. Here, M = N = 100, q1/p1 = 5, and kf/p1 = 10
−6,
were used. For reference, Qe, the corresponding probability that the virus undergoes endocytosis is also plotted.
Figure 9: (a) The mean number of receptors bound at the moment of viral fusion, and the mean number of receptors
bound at the moment of viral entry (regardless of entry pathway) plotted as functions of the normalized coreceptor
binding rate, q1/p1. (b) The mean number of coreceptors bound at the moment of fusion and endocytosis, and
the average number of coreceptors bound are plotted. The probability that the virus undergoes endocytosis, Qe
is plotted for reference. For both plots M = N = 100, kf/p1 = 0.1, ke/p1 = 1.
Figure 10: Qualitative “phase diagram” showing the regimes of parameter space in which endocytosis is dominant.
Diagrams (a),(b), and (c), correspond to fast, intermediate, and slow coreceptor binding, respectively. In all
diagrams, parameters falling within the blue region left of the vertical thick dashed line favor full viral wrapping
before fusion occurs (PM ≈ 1). In the yellow sector above the thin dashed curves, the rate of endocytosis exceeds
the effective rate of fusion in the fully wrapped state. In the green intersection of these regions, the virus is likely
to reach the fully wrapped state and undergo endocytosis. Note that when coreceptor binding is very slow (c),
the virus reaches the fully wrapped state for all values of kf .
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